Skip to search formSkip to main contentSkip to account menu

Remicade

Known as: Remicade [brand name] 
brand name of infliximab a drug used to treat autoimmune disorders
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Abstract Objectives: To evaluate the utilization patterns of the anti-tumor necrosis factor (anti-TNF) agents Humira (adalimumab… 
2010
2010
To the Editor: We read with interest the recent letter by Cordoba et al. (1), who reported on the apparent normalization of the… 
Review
2006
Review
2006
Infliximab (Remicade®) is a chimeric monoclonal antibody that binds tumour necrosis factor–alpha (TNF-α) and inhibits its… 
2003
2003
ZUSAMMENFASSUNGHintergrund: Remicade® ist ein chimärer, human-muriner, monoklonaler Antikörper. Remicade® wurde im August 1999… 
2001
2001
TNF alpha is a pro-inflammatory cytokine in Crohn's disease and it's neutralization is beneficial in patients with active disease… 
1999
1999
The chimeric anti-TNF antibody Remicade (Infliximab) has recently been approved for human use by the FDA and is now available on…